1. Home
  2. FULC vs CBK Comparison

FULC vs CBK Comparison

Compare FULC & CBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fulcrum Therapeutics Inc.

FULC

Fulcrum Therapeutics Inc.

HOLD

Current Price

$3.50

Market Cap

467.8M

Sector

Health Care

ML Signal

HOLD

CBK

Commercial Bancgroup Inc.

HOLD

Current Price

$33.08

Market Cap

392.4M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
FULC
CBK
Founded
2015
1975
Country
United States
United States
Employees
N/A
298
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
467.8M
392.4M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
FULC
CBK
Price
$3.50
$33.08
Analyst Decision
Buy
Analyst Count
8
0
Target Price
$16.38
N/A
AVG Volume (30 Days)
3.3M
91.9K
Earning Date
04-27-2026
04-27-2026
Dividend Yield
N/A
1.40%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$11.67
Revenue Next Year
N/A
$8.05
P/E Ratio
N/A
$9.10
Revenue Growth
N/A
N/A
52 Week Low
$2.83
$23.24
52 Week High
$15.74
$34.45

Technical Indicators

Market Signals
Indicator
FULC
CBK
Relative Strength Index (RSI) 34.50 66.15
Support Level $2.83 $23.90
Resistance Level $4.02 N/A
Average True Range (ATR) 0.23 0.92
MACD 0.10 -0.02
Stochastic Oscillator 13.11 63.57

Price Performance

Historical Comparison
FULC
CBK

About FULC Fulcrum Therapeutics Inc.

Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing small molecules for genetically defined rare diseases. Its product candidate, Pociredir, is an oral small molecule designed to induce fetal hemoglobin (HbF) and is in clinical development for sickle cell disease (SCD). The company completed dosing in the Phase 1b PIONEER trial evaluating pociredir in adults with SCD and reported clinical data showing clinically relevant HbF induction and improvements in markers of hemolysis and anemia. The company has also generated a pipeline of clinical-stage and pre-clinical programs targeting the root causes of rare genetic diseases.

About CBK Commercial Bancgroup Inc.

Commercial Bancgroup Inc is a bank holding company. Through its subsidiary, it operates as a full-service community banking institution offering traditional consumer and commercial products and services to businesses and individuals in select markets in Kentucky, North Carolina, and Tennessee. In Tennessee, its service areas include the metropolitan statistical areas of Nashville Davidson, Murfreesboro, Franklin, Knoxville, and the Tri Cities region of Kingsport, Bristol, and Johnson City, as well as Claiborne County, Cocke County, Union County, Hamblen County, and their surrounding areas.

Share on Social Networks: